SIAG
ISEE

Safeguard Investment Advisory Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Safeguard Investment Advisory Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-38
Closed – – 778
2020
Q4 		$0 Buy
+38
New +$243 ﹤0.01% 805

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Safeguard Investment Advisory Group's ISEE Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2021, closing a stake of 38 shares.

Safeguard Investment Advisory Group first reported a position in ISEE in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 115 funds tracked by Wall St. Rank hold ISEE as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 38 IVERIC bio, Inc. Common Stock shares in Q1 2021.
  • Safeguard Investment Advisory Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's IVERIC bio, Inc. Common Stock position peaked at $0 in Q4 2020.
  • 115 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.